Polarized Xenon Production: Powerful Narrowed Laser

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$282,207.00
Award Year:
2007
Program:
STTR
Phase:
Phase II
Contract:
2R42ES014005-02
Agency Tracking Number:
ES014005
Solicitation Year:
2007
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
XEMED, LLC
XEMED, LLC, 16 Strafford Avenue, DURHAM, NH, 03824
Hubzone Owned:
N
Socially and Economically Disadvantaged:
Y
Woman Owned:
Y
Duns:
152959891
Principal Investigator:
JAN DISTELBRINK
(603) 868-1888
JAND@PHYSICS.UNH.EDU
Business Contact:
WILLIAM HERSMAN
(603) 868-1888
hersman@unh.edu
Research Institution:
UNIVERSITY OF NEW HAMPSHIRE

UNIVERSITY OF NEW HAMPSHIRE
OFFICE OF SPONSORED RESEARCH
DURHAM, NH, 3824

Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): Hyperpolarized xenon and helium have both demonstrated utility in functional lung imaging and quantifying lung disease. Hyperpolarized xenon offers advantages of a low diffusion constant and availability from natural sources. It also has applications in dissolved state imaging, with a high solubility in fluids and tissues and a characteristic chemical shift, revealing its microscopic environment. Comparison of the dissolved and gaseous signals in lungs, for example, offers a precise measure of surface-to-volume ratio. A protocol involving a suite of lung images in three-dimensions or a program to investigate dissolved- phase imaging of perfused organs in humans could beneficially utilize large quantities of highly polarized xenon. The UNH group has developed a new type of xenon polarizer that flows the gas mixture at relatively high velocity and low pressure along a direction opposite to the laser beam, producing polarization of over 60% for small quantities and 22% for a production rate of six liters per hour. The figure-of-merit (polarization times production rate) of this polarizer presently exceeds all other polarizer technologies by an order of magnitude. The 500 torr operating pressure represents a compromise between higher laser absorption (at higher pressure) and faster spin-exchange rates (at lower pressure). Our numerical simulations indicate that magnetization output scales with absorbed laser power, that is, power within a narrow range around the spectral absorption band. Using STTR Phase I funding we have further developed our high-power spectrally narrowed laser technology for spin-exchange optical pumping of hyperpolarized gas. We scaled up our spectrally narrowed laser technology to 480W. Separately, we adapted our 5 bar 130 watt and 9 bar 270 watt lasers to investigate two new technologies to reduce the mode structure of the output beam for better collimation. We recently installed our 270 watt laser on the polarizer, and we expect polarization figures for both lasers once calibrations are set. For Phase II we will complete our study of the mode reduction technology to achieve a narrow spectral output with nearly ideal collimation. We will measure laser output as a function of mode and spectral constraints. We will investigate polarizer output as a function of laser power. We will test two different polarizer column diameters and two different polarizer column lengths to optimize the physical properties of the polarizer for increased output. We expect to come close to the goal of real-time hyperpolarized xenon production, 60 L/hr at ~50% polarization. This research to develop a high power laser will increase the production rate for producing hyperpolarized xenon. Hyperpolarized Xenon Magnetic Resonance Imaging (MRI) was recently demonstrated as an exquisitely sensitive method for assessment of lung ventilation and tissue health, with applications to quantifying obstructive lung disease and emphysema. The specific aim of the current work is to increase the production rate of hyperpolarized xenon to greater than 60 L/hr, allowing an imaging subject to breathe the gas directly from the polarizer in real time. High-volume, cost-effective production of hyperpolarized xenon will also provide a new background-free, non-recirculating contrast agent for blood and tissues which may offer unique contrast for diagnosing a broad spectrum of diseases.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government